pharmahealth

1
ACTH) Market (Source Natural and Synthetic
Indication Rheumatology, Neurology, Nephrotic
Syndrome, Ophthalmology, and Others and
Distribution Channel Hospital Pharmacies, Retail
Pharmacies, and Online PharmaciesForecast From
2019 - 2027
Adrenocorticotropic Hormone (ACTH) Market
2
Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary
Chapter 4 Market Overview
Chapter 5 Market Outlook
Chapter 6 Global Adrenocorticotropic Hormone (ACTH) Market Analysis and Forecast, by Indication 
Chapter 7 Global Adrenocorticotropic Hormone (ACTH) Market Analysis and Forecast, by Source 
Chapter 8 Global Adrenocorticotropic Hormone (ACTH) Market Analysis and Forecast, by Distribution Channel 
Chapter 9 Global Adrenocorticotropic Hormone (ACTH) Market Analysis and Forecast, by Region
Chapter 10 North America Adrenocorticotropic Hormone (ACTH) Market Analysis and Forecast
Chapter 11 Europe Adrenocorticotropic Hormone (ACTH) Market Analysis and Forecast
Chapter 12 Asia Pacific Adrenocorticotropic Hormone (ACTH) Market Analysis and Forecast
Chapter 13 Latin America Adrenocorticotropic Hormone (ACTH) Market Analysis and Forecast
Chapter 14 Middle East Africa Adrenocorticotropic Hormone (ACTH) Market Analysis and Forecast
Chapter 15 Company Profiles
3
Adrenocorticotropic Hormone (ACTH) Market

• Cortisol is an essential hormone that enables
  individuals to cope with stress, infection,
  maintain blood pressure, moderate blood sugar,
  and regulate metabolism. 
• Demand for the development of newer and
  technologically enhanced products is rising
  globally, owing to the treatment efficiency of
  drugs.
• global adrenocorticotropic hormone (ACTH) market
  based on source, indication, distribution
  channel, and region.

4
(No Transcript)
5
Reports Highlights

• Global adrenocorticotropic hormone (ACTH)
  market was valued at US 1.47 Bn in 2018 and is
  projected to expand at a CAGR of
  4 from 2019 to 2027.
• Key Players
• Mallinckrodt plc, Pfizer, Inc., Novartis AG,
  Mylan N.V., and Hikma Pharmaceuticals plc.

Request Sample
6
(No Transcript)